Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
47.55
-0.91 (-1.88%)
At close: Nov 18, 2025, 4:00 PM EST
47.28
-0.27 (-0.57%)
After-hours: Nov 18, 2025, 6:58 PM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 21.81B | 326.21M |
| Mar 31, 2025 | 20.89B | 83.10M |
| Dec 31, 2024 | 19.80B | 96.13M |
| Sep 30, 2024 | 18.25B | 102.48M |
| Jun 30, 2024 | 17.20B | 78.14M |
| Mar 31, 2024 | 16.54B | 424.04M |
| Dec 31, 2023 | 15.45B | 457.53M |
| Sep 30, 2023 | 14.04B | 359.54M |
| Jun 30, 2023 | 12.72B | 643.89M |
| Mar 31, 2023 | 11.66B | 851.19M |
| Dec 31, 2022 | 10.45B | 1.15B |
| Sep 30, 2022 | 9.65B | 1.41B |
| Jun 30, 2022 | 8.86B | 1.44B |
| Mar 31, 2022 | 8.29B | 1.45B |
| Dec 31, 2021 | 7.68B | 1.41B |
| Sep 30, 2021 | 7.25B | 1.46B |
| Jun 30, 2021 | 6.74B | 1.59B |
| Mar 31, 2021 | 6.63B | 1.56B |
| Dec 31, 2020 | 6.78B | 1.61B |
| Sep 30, 2020 | 6.77B | 1.73B |
Source: Business metrics provided by Main Street Data and sourced
from official company press releases and documents.